Agios Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Published: October 2015
No. of Pages: 37
   

Global Markets Direct’s, ‘Agios Pharmaceuticals, Inc. Product Pipeline Review 2015’, provides an overview of the Agios Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Agios Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides brief overview of Agios Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Agios Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Agios Pharmaceuticals, Inc.’s pipeline products

Reasons to buy


  • Evaluate Agios Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Agios Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Agios Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Agios Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Agios Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
  • Explore the dormant and discontinued projects of Agios Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Agios Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Agios Pharmaceuticals, Inc. Snapshot 5
Agios Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Agios Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Agios Pharmaceuticals, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
Agios Pharmaceuticals, Inc. - Pipeline Products Glance 12
Agios Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Agios Pharmaceuticals, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Agios Pharmaceuticals, Inc. - Drug Profiles 16
AG-348 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
AG-120 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
AG-881 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
AGI-14100 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
CM-4 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecule to Activate PKM2 for Cancer 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecules for Inborn Errors Of Metabolism 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecules to Inhibit Glutaminase for Cancer 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Agios Pharmaceuticals, Inc. - Pipeline Analysis 25
Agios Pharmaceuticals, Inc. - Pipeline Products by Target 25
Agios Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 26
Agios Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 27
Agios Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 28
Agios Pharmaceuticals, Inc. - Recent Pipeline Updates 29
Agios Pharmaceuticals, Inc. - Dormant Projects 34
Agios Pharmaceuticals, Inc. - Locations And Subsidiaries 35
Head Office 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 36
Disclaimer 37

List of Tables

Agios Pharmaceuticals, Inc., Key Information 5
Agios Pharmaceuticals, Inc., Key Facts 5
Agios Pharmaceuticals, Inc. - Pipeline by Indication, 2015 7
Agios Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 8
Agios Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 9
Agios Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015 10
Agios Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015 11
Agios Pharmaceuticals, Inc. - Phase II, 2015 12
Agios Pharmaceuticals, Inc. - Phase I, 2015 13
Agios Pharmaceuticals, Inc. - Preclinical, 2015 14
Agios Pharmaceuticals, Inc. - Discovery, 2015 15
Agios Pharmaceuticals, Inc. - Pipeline by Target, 2015 25
Agios Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 26
Agios Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 27
Agios Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 28
Agios Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 29
Agios Pharmaceuticals, Inc. - Dormant Developmental Projects,2015 34

List of Figures

Agios Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015 7
Agios Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 8
Agios Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 9
Agios Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015 10
Agios Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015 25
Agios Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015 26
Agios Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015 27
Agios Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 28

Published By: Global Markets Direct
Product Code: Global Markets Direct13277


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we�ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Pharmaceuticals market as per your needs. Get the best of Pharmaceuticals research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: